Elevai Labs, Common Stock Today
| ELAB Stock | 6.40 0.76 13.48% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Elevai Labs, is trading at 6.40 as of the 20th of March 2025, a 13.48 percent up since the beginning of the trading day. The stock's open price was 5.64. Elevai Labs, has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of November 2023 | Category Healthcare | Classification Health Care |
Elevai Labs, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 577 K outstanding shares of which 185.68 K shares are currently shorted by private and institutional investors with about 0.26 trading days to cover. More on Elevai Labs, Common
Moving together with Elevai Stock
Moving against Elevai Stock
Elevai Stock Highlights
| President CoFounder | Jordan Plews | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Biotechnology, Healthcare (View all Sectors) | ||||
Elevai Labs, can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Elevai Labs,'s financial leverage. It provides some insight into what part of Elevai Labs,'s total assets is financed by creditors.
| |||||
Elevai Labs, Common (ELAB) is traded on NASDAQ Exchange in USA. It is located in 120 Newport Center Drive, Newport Beach, CA, United States, 92660 and employs 18 people. Elevai Labs, is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.69 M. Elevai Labs, Common conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 577 K outstanding shares of which 185.68 K shares are currently shorted by private and institutional investors with about 0.26 trading days to cover.
Elevai Labs, generates negative cash flow from operations
Check Elevai Labs, Probability Of Bankruptcy
Ownership AllocationRoughly 97.93 percent of Elevai Labs, outstanding shares are held by general public with 1.15 (percent) owned by insiders and only 0.92 % by other corporate entities.
Check Elevai Ownership Details
Elevai Labs, Historical Income Statement
Elevai Stock Against Markets
Elevai Labs, Corporate Executives
Elected by the shareholders, the Elevai Labs,'s board of directors comprises two types of representatives: Elevai Labs, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevai. The board's role is to monitor Elevai Labs,'s management team and ensure that shareholders' interests are well served. Elevai Labs,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevai Labs,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| FACS FACS | Chief CoFounder | Profile | |
| Graydon CFA | Secretary CFO | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (622.43) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.